Showing results (281-290 of 505) with videos related to

Sort By:
Pageof 51
Infection & Chemotherapy|September 24, 2016
Mortality Risk Factors for Patients with Septic Shock after Implementation of the Surviving Sepsis Campaign BundlesJe Eun Song, Moo Hyun Kim, Woo Yong Jeong, et al.
Biochemical and Biophysical Research Communications|April 17, 2014
A novel cantharidin analog N-benzylcantharidinamide reduces the expression of MMP-9 and invasive potentials of Hep3B via inhibiting cytosolic translocation of HuRJi-Yeon Lee, Tae-Wook Chung, Hee-Jung Choi, et al.
Plos One|May 9, 2024
Correction: Increasing Fusobacterium infections with Fusobacterium varium, an emerging pathogenSe Ju Lee, Yae Jee Baek, Jin Nam Kim, et al.
Trials|June 14, 2011
Evaluation of wet-cupping therapy for persistent non-specific low back pain: a randomised, waiting-list controlled, open-label, parallel-group pilot trialJong-In Kim, Tae-Hun Kim, Myeong Soo Lee, et al.
The Tohoku Journal of Experimental Medicine|September 25, 2009
Prevalence of and clinical factors associated with lipoatrophy in HIV-infected Koreans receiving highly active antiretroviral therapySang Hoon Han, Bum Sik Chin, Hee Kyoung Choi, et al.
Critical Care (London, England)|December 11, 2013
An increase in red blood cell distribution width from baseline predicts mortality in patients with severe sepsis or septic shockChan Ho Kim, Jung Tak Park, Eun Jin Kim, et al.
Infection & Chemotherapy|August 7, 2020
A Case of African Tick-Bite Fever in a Returning Traveler from Southern AfricaWoonji Lee, Hye Seong, Jung Ho Kim, et al.
Nature Communications|August 1, 2025
A randomized, double-blind, placebo-controlled trial of niclosamide nanohybrid for the treatment of patients with mild to moderate COVID-19Jung Ho Kim, Sungmin Kym, Shin-Woo Kim, et al.
Infection & Chemotherapy|January 4, 2026
COVID-19 Vaccination Recommendations for 2025-2026 in KoreaWan Beom Park, Young Hoon Hwang, Ki Tae Kwon, et al.
Plos One|January 10, 2013
Abnormal liver stiffness assessed using transient elastography (Fibroscan®) in HIV-infected patients without HBV/HCV coinfection receiving combined antiretroviral treatmentSang Hoon Han, Seung Up Kim, Chang Oh Kim, et al.
Pageof 51